Abstract
Nusinersen is the first approved drug to treat spinal muscular atrophy (SMA). Its periodic intrathecal delivery may cause psychological burden in infants and in their parents. We report our experience during expanded access program (EAP) for type 1 SMA in a single Italian center. Because of the occurrence of stress emotional states, anxious reactions and fear before, during, and after lumbar puncture (LP), a specific psychological intervention was implemented based on regulation of emotions, anticipatory expectations, and post-event attributions. Activities included the use of fairy tales, distraction, music play through listening preferred cartoon themes in the youngest children, and contextual games and solution of fun riddle quizzes in the oldest ones. State anxiety greatly reduced in children and their parents. Treatment of psychological aspects should therefore become an integral part of health care in SMA infants and children during Nusinersen treatment.
References
Messina S, Pane M, Sansone V, Bruno C, Catteruccia M, Vita G, Palermo C, Albamonte E, Pedemonte M, Bertini E, Binetti L, Mercuri E, Lauro D, Pallara A, Spinoglio S, Solinas ML, Zappa G, Penno F, Ponzanelli C, Casiraghi J, Villanova M, Tiziano D, Mandelli A, Mastella C, Fontana A, Ambrosini A, Leone D, de Sanctis R, Forcina N, Piastra M, Genovese O, Pedicelli A, Sframeli M, Versaci A, Rulli I, Gitto E, Faraone C, la Foresta S, Macrì M, D’Amico A, Colia G, Bonetti AM, Carlesi A, Cutrera R, Chiarini MB, Ferretti M, Garaventa A, Montobbio G, Gandolfo C, Iurilli V, Tacchetti P, Bobeica E, D’Agostino A, Pirola A, Luppone S, de Mattia E, Falcier E, Rao F, Fedeli F, Mancini L, Stoia P, Heinen M, Cozzi V, Travaglia B, Mizzotti E (2017) Expanded access program with Nusinersen in SMA type I in Italy: strengths and pitfalls of a successful experience. Neuromuscul Disord 27:1084–1086
Sansone VA, Pane M, Messina S, Bruno C, D’Amico A, Albamonte E, Catteruccia M, Sframeli M, Pedemonte M, Vita G, Bertini E, Mercuri E, Leone D, de Sanctis R, Forcina N, Piastra M, Genovese O, Pedicelli A, Versaci A, Rulli I, Gitto E, Faraone C, la Foresta S, Macrì M, Colia G, Bonetti AM, Carlesi A, Cutrera R, Chiarini MB, Ferretti M, Garaventa A, Montobbio G, Gandolfo C, Iurilli V, Tacchetti P, Bobeica E, D’Agostino A, Pirola A, Lupone S, de Mattia E, Falcier E, Rao F, Casiraghi J, Salmin F, Grandi C, Fedeli F, Mancini L, Stoia P, Heinen M, Cozzi V, Travaglia B, Mizzotti E (2018) A 5-center experience with intrathecal administration of Nusinersen in SMA1 in Italy. Eur J Paediatr Neurol 22:729–731
Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, et al (2018) Nusinersen in type 1 SMA infants, children and young adults: preliminary results on motor function. Neuromuscul Disord Jun 1. pii: S0960-8966(18)30283-9. doi: https://doi.org/10.1016/j.nmd.2018.05.010. [Epub ahead of print]
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto (CA)
Spielberger CD, Edwards CD, Montuori J, Lushene R. (1973) State-Trait Anxiety Inventory for Children. Consulting Psychologist Press, Palo Alto (CA)
Chand SP, Whitten RA (2017) Cognitive behavior therapy (CBT). StatPearls Publishing, Treasure Island (FL)
Scott HK, Cogburn M (2017) Behavior modification. StatPearls Publishing, Treasure Island (FL)
Fond G, Franc N (2013) Treating specific childhood phobia in a single session? A systematic review of the literature. Encephale 39:109–114
Mercuri E, Bertini E, Iannaccone ST (2012) Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol 11:443–452
von Gontard A, Rudnik-Schöneborn S, Zerres K (2012) Stress and coping in parents of children and adolescents with spinal muscular atrophy. Klin Padiatr 224:247–251
Lövgren M, Sejersen T, Kreicbergs U (2016) Parents’ experiences and wishes at end of life in children with spinal muscular atrophy types I and II. J Pediatr 175:201–205
Cuzzocrea F, Gugliandolo MC, Larcan R, Romeo C, Turiaco N, Dominici T (2013) A psychological preoperative program: effects on anxiety and cooperative behaviors. Paediatr Anaesth 23:139–143
Bergomi P, Scudeller L, Pintaldi S, Dal Molin A (2018) Efficacy of non-pharmacological methods of pain management in children undergoing venipuncture in a pediatric outpatient clinic: a randomized controlled trial of audiovisual distraction and external cold and vibration. J Pediatr Nurs May 1. pii: S0882–5963(17)30536–5. doi: https://doi.org/10.1016/j.pedn.2018.04.011. [Epub ahead of print]
Cuzzocrea F, Costa S, Gugliandolo MC, Larcan R (2016) Psychologists in preoperative programmes for children undergoing surgery. J Child Health Care 20:164–173
Acknowledgements
We thank type 1 SMA infants and children and their parents.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
La Foresta, S., Faraone, C., Sframeli, M. et al. Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center. Neurol Sci 39, 1961–1964 (2018). https://doi.org/10.1007/s10072-018-3506-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3506-z